Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a 13 week, randomised, double blind study versus placebo and celecoxib.

MLA

Tannenbaum, H., et al. “Lumiracoxib Is Effective in the Treatment of Osteoarthritis of the Knee: A 13 Week, Randomised, Double Blind Study versus Placebo and Celecoxib.” Annals of the Rheumatic Diseases, Nov. 2004, pp. 1419–26. EBSCOhost, https://doi.org/10.1136/ard.2003.015974.

APA

Tannenbaum, H., Berenbaum, F., Reginster, J.-Y., Zacher, J., Robinson, J., Poor, G., Bliddal, H., Uebelhart, D., Adami, S., Navarro, F., Lee, A., Moore, A., & Gimona, A. (2004). Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a 13 week, randomised, double blind study versus placebo and celecoxib. Annals of the Rheumatic Diseases, 1419–1426. https://doi.org/10.1136/ard.2003.015974

Chicago

Tannenbaum, H., F. Berenbaum, J.-Y. Reginster, J. Zacher, J. Robinson, G. Poor, H. Bliddal, et al. 2004. “Lumiracoxib Is Effective in the Treatment of Osteoarthritis of the Knee: A 13 Week, Randomised, Double Blind Study versus Placebo and Celecoxib.” Annals of the Rheumatic Diseases, November, 1419–26. doi:10.1136/ard.2003.015974.